INTECH Investment Management’s Soleno Therapeutics SLNO Stock Holding History

INTECH Investment Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,109	Closed	-$472K	–	2259
2026 Q1	$472K	Sell	14,109 -4,237	-23%	-$166K	﹤0.01%	1354
2025 Q4	$849K	Sell	18,346 -4,241	-19%	-$233K	0.01%	1221
2025 Q3	$1.53M	Sell	22,587 -6,619	-23%	-$491K	0.01%	935
2025 Q2	$2.45M	Buy	29,206 +21,588	+283%	+$1.62M	0.02%	644
2025 Q1	$544K	Sell	7,618 -1,662	-18%	-$80.9K	0.01%	1564
2024 Q4	$417K	Buy	9,280 +4,090	+79%	+$212K	﹤0.01%	1658
2024 Q3	$262K	Buy	+5,190	New	+$248K	﹤0.01%	1590

INTECH Investment Management's SLNO Position: Q2 2026 in Review

INTECH Investment Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 14,109 shares — an estimated $472K sold.

INTECH Investment Management first reported a position in SLNO in Q3 2024 and held it in 7 quarters. The position peaked at $2.45M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

INTECH Investment Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
INTECH Investment Management sold 14,109 Soleno Therapeutics shares in Q2 2026, an estimated $472K.
INTECH Investment Management first reported a position in Soleno Therapeutics in Q3 2024 and held it in 7 quarters.
INTECH Investment Management's Soleno Therapeutics position peaked at $2.45M in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.